Subject Index Volume 169 (2013)

19F-MRI, (169) 14110-Hydrocamptothecin (HCPT), (169) 329

Alginate, (169) 321Amine salt, (169) 73Amphiphilic block copolymer, (169) 204Angiogenesis, (169) 91Anticancer, (169) 329Anticancer drugs, (169) 171, (169) 185Anti-oxidant, (169) 306Antitumor drug delivery, (169) 193Apical junctional complex, (169) 296

Bioadhesion, (169) 62Biocompatibility, (169) 246Biodegradability, (169) 239, (169) 289Biodegradable copolymers, (169) 185Biodegradable micelles, (169) 171Bladder cancer, (169) 62Blood–brain barrier, (169) 103Blood, (169) 91Brain, (169) 103Boronic acid, (169) 266

Calcium depletion, (169) 296Camptothecin (CPT), (169) 329Cancer, (169) 10Cancer diagnosis, (169) 180Cancer nanotechnology, (169) 185Cancer therapy, (169) 165Carbohydrate interaction, (169) 266Cardiomyocytes, (169) 336Cavitation, (169) 40Cell-free, (169) 91Cell sheet, (169) 336Cell uptake, (169) 17Central composite design, (169) 73Chelating agent, (169) 296Chemotherapy, (169) 112, (169) 103Chitosan, (169) 257Ciprofloxacin hydrochloride, (169) 313Co-delivery, (169) 211Combination therapy, (169) 185Compound transdermal patch, (169) 73Conjugation, (169) 204Contrast agent, (169) 239Controlled delivery, (169) 28Controlled drug delivery, (169) 165Controlled release, (169) 171, (169) 228

c(RGDfK) peptide, (169) 204Cytarabine, (169) 17

Delivery, (169) 40Dendrimer, (169) 239, (169) 276Dendritic cells, (169) 141Device, (169) 91Dextran, (169) 266Diabetic rats, (169) 341Doxorubicin, (169) 48, (169) 211Drug conjugates, (169) 126Drug delivery, (169) 48, (169) 82, (169) 103, (169) 112, (169) 126,

(169) 313Drug delivery system, (169) 220Drug intercalation, (169) 28Drug-material interaction, (169) 329Drug release kinetics, (169) 126Drug release mechanism, (169) 126Doxorubicin, (169) 48, (169) 211Dual-responsive, (169) 171

Endocytosis, (169) 17Enzyme inhibition, (169) 296Ethanol, (169) 1Ethylcellulose, (169) 1

Factor delivery, (169) 91Fibre-spinning, (169) 313Film coating, (169) 1Focused ultrasound, (169) 82, (169) 103Folate, (169) 257Furosemide, (169) 48, (169) 150

Gene delivery, (169) 246, (169) 266Glioma, (169) 103Gold nanocarriers, (169) 48Guar gum, (169) 1

Heart failure, (169) 336Hepatoma-targetability, (169) 193Hydrogel, (169) 321Hydrolysis, (169) 17Hyperbranched polymer, (169) 276Hyperthermia, (169) 82, (169) 165Hypoxia, (169) 91

Image guidance, (169) 82Immunotherapy, (169) 141

Journal of Controlled Release 169 (2013) e11–e12

doi:10.1016/S0168-3659(13)00294-0

Contents lists available at SciVerse ScienceDirect

Journal of Controlled Release

j ourna l homepage: www.e lsev ie r.com/ locate / jconre l

Implantable biosensors, (169) 341Inherently conducting polymer, (169) 313Intra-articular drug delivery, (169) 73Intravesical therapy, (169) 62Iron oxide, (169) 211Iron oxide nanocarriers, (169) 48Ischemia/reperfusion, (169) 306

Layered double hydroxide, (169) 28Long-circulating nanocarriers, (169) 10Lornoxicam, (169) 73Lysosome, (169) 17

Magnetic field, (169) 165Magnetic resonance imaging (MRI), (169) 220, (169) 228Malignancy therapy, (169) 193Metallothionein, (169) 306Micelles, (169) 204MRI, (169) 239Multifunctional nanoparticles, (169) 211Multimaterial drug carrier, (169) 321Multi-wall carbon nanotubes, (169) 126Myocardial infarction, (169) 306

Nanocapsules, (169) 10Nanodispersion, (169) 150Nanomedicine, (169) 185, (169) 193Nanomedicines, (169) 10Nanoparticle, (169) 150, (169) 246Nanoparticles, (169) 180Nanoprecipitation, (169) 289Non-viral gene delivery, (169) 276NMP, (169) 211NSAID, (169) 28

Oncolytic, (169) 40Oncolytic adenovirus, (169) 257Oral protein delivery, (169) 296Organic–inorganic nanohybrids, (169) 28Oxidised multi-wall carbon nanotubes, (169) 126

PEGylation, (169) 228Pellets, (169) 1Perfluorocarbon, (169) 141Permeability, (169) 150, (169) 161pH sensitive, (169) 180, (169) 228PLGA/PVA “smart” composite coatings, (169) 341Poly(alkyl-2-cyanoacrylate), (169) 321Poly(amido amine), (169) 266Poly(ethylene glycol), (169) 257Poly(ethylene glycol) (PEG), (169) 329

Poly(lactide-co-glycolide), (169) 62Polyion complex vesicles (PICsomes), (169) 220Polyglutamic acid, (169) 10Polyglycerol nanogel, (169) 289Polylysine, (169) 276Polymer, (169) 246Polymer coating, (169) 321Polymeric micelles, (169) 180Polymersomes, (169) 165Polypeptide, (169) 193Protein encapsulation, (169) 289Protein transduction domain, (169) 306

Ribonucleotide reductase, (169) 17

SPECT, (169) 82Solid dispersion, (169) 150Solubility, (169) 150Stem cells, (169) 336Stimuli-responsive release, (169) 289Stimuli-sensitive, (169) 171Superficial bladder cancer, (169) 204Superparamagnetic iron-oxide (SPIO) nanocomposites, (169) 228Superparamagnetic iron oxide nanoparticles (SPIOs), (169) 220Surfactant free, (169) 289

Targeted therapy, (169) 180Targeting drug delivery, (169) 204Taxanes, (169) 185Teriflunomide, (169) 73Temperature-sensitive liposomes, (169) 82Theranostic, (169) 141, (169) 165Theranostics, (169) 228Thermosensitive liposomes, (169) 112Thermosensitive polymers, (169) 112Topotecan (TPT), (169) 329Trafficking, (169) 276Transient gene expression, (169) 276Triggered release, (169) 246Tumor, (169) 40Tumor diagnosis, (169) 220Tumor imaging, (169) 239

Ultrasound, (169) 40Urothelium, (169) 62

Wheat germ agglutinin, (169) 62

e12Subject Index Volume 167 (2013) e11–e12